FDA Warning Letter — Invitrx Therapeutics Inc.

Case 630712 — FEI 3015252551

The FDA took a Warning Letter action against Invitrx Therapeutics Inc. on November 9, 2022 (Lake Forest, CA). The action was issued by CBER and concerns biologics products. This facility has 3 recent FDA inspections on record.

Action Details

Facility
Invitrx Therapeutics Inc.
Date
November 9, 2022
Fiscal Year
2023
Product Type
Biologics
Center
CBER
Location
Lake Forest, CA (United States)